Larvol Delta - Compass-Pathways-Announces-SixMonth-Data-from-Second-Phase-3-Trial-Conrming-Rapid-and-Durable-Prole

psilocybin (COMP360) - Compass Pathways

https://www.businesswire.com/news/home/20260707713443/en/Compass-Pathways-Announces-Six-Month-Data-from-Second-Phase-3-Trial-Confirming-Rapid-and-Durable-Profile

Jul 7, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next